#ACR21 Rheum Secrets and Pearls High CRP - not a typical marker of SLE flare. Look for infection! @Rheumnow https://t.co/g1Z6OHvANv

Do you use RAPID3 in PsA? Abst#0633 at #ACR21 shows a strong agreement between RAPID3 remission score w/ DAPSA + cDAPSA, esp when redefining RAPID3 categories. Is this practice △ing? With more studies to validate, yes, since RAPID3 is simpler! @RheumNow https://t.co/2q0FLeBSkC https://t.co/M3WDTGzEOT

• Value of the Routine Assessment of Patient Index Data 3 (RAPID3) as a Disease A…

Always one of my favourite sessions at #ACR21- #Rheumatology #SecretsAndPearls Dr Kolfenbach reminds us of the importance of discussing #lifestyle, #smoking and #diet with our patients in clinic. @RheumNow #InflammatoryArthritis #RheumatoidArthritis #PsA https://t.co/2gadRBLCTb

VITAL RCT of Omega-3 and Vit D in preventing autoimmune diseases in 25,871 individuals. They both work! Reducing incident autoimmune disease by 25-30%. This is game-changing! Abstr#0957 #ACR21 @RheumNow #ACRBest https://t.co/BaeZDTTnQf

Elevated CRP? Dr. Kolfenbach reminds us that it is not typical of #SLE flares, rule out INFECTION! @RheumNow #ACR21 #RheumTwitter #MedTwitter https://t.co/FnkPdZ8gSl

"We need to do more than improving quality of care to close the gap in racial disparities." - Dr. J Chang Trends of adverse renal outcomes⬇️w/time in children hosp w/SLE. Improvements seen across racial/ethnic group, but black-white disparity persists abst#0956 #ACR21 @rheumnow https://t.co/HcOwQiKCb2

#ACR21 Rheum Secrets and Pearls Is it Allopurinol or adherence concern? Oxypurinol can be helpful in measuring adherence! Kolfenbach: "I despise the term non-compliant patient." Address the many reasons why adherence may be low! Health literacy is key. @Rheumnow https://t.co/CPJ8kvqcCm

Although baseline dz was similar in axSpA males/females, study found male pts had more improvements in ASDAS-CRP, CRP, and PGA than females in 6 years of follow-up. Abs 0620 #ACR21 #RheumNow @RheumNow https://t.co/Qr657YeniA https://t.co/35t4oIUSmS

• Is There a Difference in Disease Activity Between Genders in Axial Spondyloarth…

An ongoing axSpA cohort in Netherlands study assessed the rate of progression of nr-axSpA to AS patients over a 6 y period Every 2 y approximately 10% of patients progressed from nr-axSpA to AS Abst # 0907 #ACR21 @RheumNow https://t.co/gGhhssLS5N

#ACR21 Abst#0836. TCZ switch from IV▶️SC in RA ⭐️11/37 ineffective on SC (30%) ⭐️TCZ IV >8mg/kg, no MTX, h/o ABA failure ass w/ risk of flare on SQ switch 🔥Very relevant w shortages, want more data re: confounders (adherence, disease control) https://t.co/E9pD4SrXqz @Rheumnow

• https://bit.ly/3keDrHK

Getting closer to personalised medicine in AS, ECM-mediated biomarkers may help predict response to Adalimumab in AS. The biomarkers C1M, C6M and PRO-C4 were lower in responders to adalimumab treatment after 24 weeks @RheumNow #ACR21 Abst#0915 https://t.co/K2YxPvUAwu https://t.co/w9kcBSFeG9

• Biomarkers of Extracellular Matrix Turnover Reflect Treatment Response and Phar…

Interesting study. 79 nr-axSpA pts observed for 6 years. Every 2 yrs approximately 10% of pts progressed from nr-axSpA to AS! Next step: evaluate dz characteristics and determine potential at risk pts. Abs 0907 #ACR21 #RheumNow @RheumNow https://t.co/aRjXWjkVKg https://t.co/BiHFgDR8Kv

• Radiographic Sacroiliitis Progression up to Six Years of Follow-Up in Patients …

Abst0898 #ACR21 @RheumNow MRI findings of Vertebral Corner Inflammation & Vertebral Corner Fat Deposition associated w/syndesmophyte formation 2 y later, ORs 1.87-2.58 for various VCI/VCFD patterns. Protection against syndesmophyte seen if both VCI and VCFD were absent (OR 0.35) https://t.co/t01nxdEwON

Younger patients and African Americans have a high no show rate. Need to focus on high-risk individuals and improve access to new patient appointments. @rheumnow #ACR21 abst#0610 https://t.co/3XZmXWfili